Crisis in the Care of Allergic Patients in Australia

NAS advocacy5 April 2019

pdfCrisis in the Care of Allergic Patients in Australia154.34 KB

“We are talking about young people dying and going into emergency departments, in most cases due to anaphylaxis that could have been avoided,” claims Associate Professor Richard Loh, a leading children’s allergy specialist.  “And the irony is that allergy specialists, GPs, families and consumers who live with allergy have developed a comprehensive solution. It just needs the political will and commitment from all parties, and at all levels of the health care system, to provide leadership to implement the strategy. We must also have adequate funding or else we will progress slowly or not at all and Australians will continue to be at risk.”

“The National Allergy Strategy was developed using the best available evidence and aligned with the experience of consumers,” says Maria Said, CEO of Allergy & Anaphylaxis Australia and a parent of a young adult with severe allergies who has been advocating for people with allergic disease for more than 25 years.  “Families living with a child or young adult with food allergy, live life being fearful. They don’t trust food labels and they don’t trust the health care system to do the right thing, and that’s just food allergy. There are many thousands of people who are unsure whether they have a drug allergy, who can either be wrongly denied medication or be given it unknowingly.”

“The increased allergy rates amongst children and adults have put an enormous burden on the health care system. Many doctors have not had enough support or allergy training,” says Associate Professor Loh. “This means that allergy specialists like me see young people who should be managed by their GP, and could be, if GPs felt more confident. Others who should see an allergy specialist for severe allergies are left to manage themselves leaving them at even greater risk. Many people in rural and regional areas are travelling unacceptable, costly distances for health care at huge costs to both the family and the health system.”

“With relatively small investments we could take a ‘whole of health’ approach from the ground up, because it needs comprehensive action to avoid delays in accurate diagnosis and best practice treatment,” says Maria Said, who is also a registered nurse. “People can either have unnecessary food restrictions or insufficient restrictions because they are poorly diagnosed.”

“On top of that, patients are put at risk because we do not have standards of care for anaphylaxis in Australia - these need to be developed and implemented. When children have a severe allergic reaction, many don’t receive the right emergency care and are often sent home without self-injectable adrenaline. These people need food to sustain their life but without appropriate care and ongoing management it could be food that actually kills them. It is not a lifestyle choice,” continued Ms Said.

“The National Allergy Strategy calls for a top to bottom approach,” says Associate Professor Loh.  “That includes a system such as an anaphylaxis register or notification scheme, which collects better data on things such as unsafe foods which don’t have accurate ingredient labels. It also includes training of health professionals and food service providers so that more people can receive quality care, better training in the food service industry, better access to emerging treatments for food allergies, immunotherapy for insect sting allergy, better diagnosis of drug allergies, and much more.”

“While there is no cure for food allergy, continued funding to help prevent allergies is critical, such as implementing infant feeding guidelines,” continued Associate Professor Loh.

“All political parties have publicly endorsed their commitment to the strategy, but serious funding is required to do what needs to be done. An investment of just $20 million would go a long way to getting some of this off the ground,” says Maria Said.

“That’s less than the cost of some of the cancer medications that have been approved in recent years. We applaud those approvals and hope that political parties also provide funding to prevent the development of allergic diseases and to improve care of those with allergic diseases.  Allergic disease is one of the fastest growing chronic diseases in Australia and must not be the poor cousin. The impact on quality of life is greater than that of diabetes or rheumatoid arthritis,” finished Ms Said.  

 How will the National Allergy Strategy address these issues?

The National Allergy Strategy is asking for $20 million funding over five years to allow implementation of the following important projects:


The National Allergy Strategy’s election platform available here:

Media case studies available upon request.

About the National Allergy Strategy

The National Allergy Strategy aims to improve the health and quality of life of Australians with allergic diseases and minimise the burden of allergic diseases on individuals, carers, healthcare services and the community.

The National Allergy Strategy is a partnership led by the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), the leading medical and patient organisations for allergy in Australia. 

Distributed by Lanham PR on behalf of the National Allergy Strategy

Media contact: Fleur Townley | This email address is being protected from spambots. You need JavaScript enabled to view it. | 0405 278 758


National Allergy Strategy petition and World Allergy Week 2019

World Allergy Week is a global campaign of the World Allergy Organisation (WAO) which aims to raise awareness of the impact of allergy in our communities.  World Allergy Week 2019 runs from 7-13 April and the focus area is food allergy.  

In the lead up to World Allergy Week 2019, we encourage anyone who is affected by allergy to support the National Allergy Strategy's $20 million election plea to all major political parties, by signing a petition and sharing it with family and friends.  

The core issues in allergy management revolve around effective prevention and accurate and prompt diagnosis - being treated by the right level of health professional at the right time, including support and education for families. Delays in diagnosis and management can result in:

Patients are put at risk because health professionals need better education and resources and standards of care for anaphylaxis need to be developed and implemented.

One study reviewed anaphylaxis management in eight Australian emergency departments and found that:

There is inadequate reporting to enable us to understand the size of the problem and respond appropriately. For example, there is currently only an anaphylaxis notification scheme in Victoria, implemented in response to a death. Established in Victorian Emergency Departments late last year there have already been 948 presentations of anaphylaxis since Nov 1, 2018iii. Implementing a register in all states and territories would allow the removal of unsafe foods (due to undeclared allergens) from the market place quickly and enable government to better understand the incidence of anaphylaxis to inform public health policy, interventions and research.

More work needs to be done in relation to drug allergies. Many patients are incorrectly labelled as being allergic to an antibiotic when they are not – this means they are not being given the right course of antibiotics when they need it.  While others who have life threatening reactions to a drug, are inadvertently being given the drug, causing preventable life-threatening emergencies. We need a whole of health approach to address this.

General Allergy data



[ii] National Allergy Strategy. 2015.


[iv] Brown SGA et al. Anaphylaxis: Clinical patterns, mediator release, and severity. JACI. 2013; 132 (5): 1141-9.

[v] Murad A, Katelaris C. Anaphylaxis audit in a busy metropolitan emergency department: a review of real life management compared to best practice. Asia Pacific Allergy. 2016; 6: 29-34.

[vi] Sasaki M, Koplin JJ, Dharmage SC, Field MJ, Sawyer SM, McWilliam V, Peters RL, Gurrin LC, Vuillermin PJ, Douglass J, Pezic A, Brewerton M, Tang MLK, Patton GC, Allen KJ. Prevalence of clinic-defined food allergy in early adolescence: the School Nuts study. J Allergy Clin Immunol 2017;DOI: 

[vii] De Swarte R. Drug allergy – problems and strategies. J Allergy Clin Immunol. 1984; 74: 209-221

[viii] SA Department of Health. Food Act Report: Year ending 30 June 2010. 2010:36.

[ix] Tang MLK, Mullins RJ. Food allergy: is prevalence increasing? IMJ. 2017. doi:10.1111/imj.13362

[x] Mullins et al. Anaphylaxis Fatalities in Australia 1997 to 2013. JACI. 2016. 137 (2): Suppl AB57. DOI: 10.1016/j.jaci.2015.12.189